nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT1A1—lung cancer	0.246	0.694	CbGaD
Fluvastatin—CYP1A1—lung cancer	0.108	0.306	CbGaD
Fluvastatin—SLCO2B1—Erlotinib—lung cancer	0.0323	0.0756	CbGbCtD
Fluvastatin—SLCO1B3—Paclitaxel—lung cancer	0.0262	0.0615	CbGbCtD
Fluvastatin—UGT1A1—Erlotinib—lung cancer	0.0241	0.0565	CbGbCtD
Fluvastatin—UGT1A1—Irinotecan—lung cancer	0.0218	0.051	CbGbCtD
Fluvastatin—CYP1A1—Gefitinib—lung cancer	0.0207	0.0485	CbGbCtD
Fluvastatin—SLCO1B3—Docetaxel—lung cancer	0.019	0.0444	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—lung cancer	0.0174	0.0409	CbGbCtD
Fluvastatin—SLCO1B1—Irinotecan—lung cancer	0.0151	0.0353	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—lung cancer	0.0137	0.0321	CbGbCtD
Fluvastatin—CYP3A5—Gefitinib—lung cancer	0.0124	0.0291	CbGbCtD
Fluvastatin—CYP1A1—Erlotinib—lung cancer	0.0122	0.0287	CbGbCtD
Fluvastatin—CYP3A5—Teniposide—lung cancer	0.012	0.0282	CbGbCtD
Fluvastatin—CYP2C19—Gefitinib—lung cancer	0.01	0.0235	CbGbCtD
Fluvastatin—CYP2C19—Teniposide—lung cancer	0.00971	0.0228	CbGbCtD
Fluvastatin—CYP2B6—Irinotecan—lung cancer	0.00842	0.0197	CbGbCtD
Fluvastatin—CYP2C9—Gefitinib—lung cancer	0.00833	0.0195	CbGbCtD
Fluvastatin—CYP2C9—Teniposide—lung cancer	0.00807	0.0189	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—lung cancer	0.00797	0.0187	CbGbCtD
Fluvastatin—CYP2D6—Gefitinib—lung cancer	0.00761	0.0179	CbGbCtD
Fluvastatin—CYP3A5—Crizotinib—lung cancer	0.00761	0.0178	CbGbCtD
Fluvastatin—CYP3A5—Erlotinib—lung cancer	0.00734	0.0172	CbGbCtD
Fluvastatin—CYP2C8—Erlotinib—lung cancer	0.00706	0.0166	CbGbCtD
Fluvastatin—CYP2B6—Cisplatin—lung cancer	0.00686	0.0161	CbGbCtD
Fluvastatin—CYP3A5—Paclitaxel—lung cancer	0.00672	0.0158	CbGbCtD
Fluvastatin—CYP3A5—Irinotecan—lung cancer	0.00663	0.0155	CbGbCtD
Fluvastatin—CYP2C8—Paclitaxel—lung cancer	0.00646	0.0152	CbGbCtD
Fluvastatin—CYP2D6—Vinorelbine—lung cancer	0.00587	0.0138	CbGbCtD
Fluvastatin—CYP1A2—Erlotinib—lung cancer	0.00546	0.0128	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—lung cancer	0.00531	0.0125	CbGbCtD
Fluvastatin—CYP3A4—Topotecan—lung cancer	0.00529	0.0124	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—lung cancer	0.00511	0.012	CbGbCtD
Fluvastatin—CYP3A5—Docetaxel—lung cancer	0.00486	0.0114	CbGbCtD
Fluvastatin—CYP3A4—Gefitinib—lung cancer	0.00484	0.0114	CbGbCtD
Fluvastatin—CYP3A4—Teniposide—lung cancer	0.00469	0.011	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—lung cancer	0.0046	0.0108	CbGbCtD
Fluvastatin—CYP2C9—Paclitaxel—lung cancer	0.00451	0.0106	CbGbCtD
Fluvastatin—CYP2D6—Erlotinib—lung cancer	0.0045	0.0106	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—lung cancer	0.00395	0.00927	CbGbCtD
Fluvastatin—CYP3A4—Vinorelbine—lung cancer	0.00373	0.00875	CbGbCtD
Fluvastatin—CYP2C9—Cisplatin—lung cancer	0.00362	0.0085	CbGbCtD
Fluvastatin—CYP2D6—Vinblastine—lung cancer	0.00361	0.00848	CbGbCtD
Fluvastatin—CYP3A4—Crizotinib—lung cancer	0.00297	0.00696	CbGbCtD
Fluvastatin—CYP3A4—Erlotinib—lung cancer	0.00286	0.00671	CbGbCtD
Fluvastatin—CYP3A4—Paclitaxel—lung cancer	0.00262	0.00614	CbGbCtD
Fluvastatin—CYP3A4—Irinotecan—lung cancer	0.00259	0.00606	CbGbCtD
Fluvastatin—CYP3A4—Vinblastine—lung cancer	0.0023	0.00539	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—lung cancer	0.00222	0.00521	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—lung cancer	0.00207	0.00486	CbGbCtD
Fluvastatin—CYP3A4—Docetaxel—lung cancer	0.00189	0.00444	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—lung cancer	0.00141	0.00331	CbGbCtD
Fluvastatin—Atorvastatin—AHR—lung cancer	0.000985	0.279	CrCbGaD
Fluvastatin—Atorvastatin—UGT1A1—lung cancer	0.000694	0.196	CrCbGaD
Fluvastatin—Rosuvastatin—ABCG2—lung cancer	0.000554	0.157	CrCbGaD
Fluvastatin—SLCO1B1—mammary gland—lung cancer	0.000543	0.0783	CbGeAlD
Fluvastatin—Pitavastatin—ABCG2—lung cancer	0.000484	0.137	CrCbGaD
Fluvastatin—SLCO2B1—mammary gland—lung cancer	0.00048	0.0692	CbGeAlD
Fluvastatin—HMGCR—respiratory system—lung cancer	0.000378	0.0545	CbGeAlD
Fluvastatin—SLCO1B3—lung—lung cancer	0.000332	0.0479	CbGeAlD
Fluvastatin—SLC15A1—epithelium—lung cancer	0.000327	0.0471	CbGeAlD
Fluvastatin—SLCO2B1—respiratory system—lung cancer	0.00032	0.0461	CbGeAlD
Fluvastatin—HMGCR—epithelium—lung cancer	0.000316	0.0455	CbGeAlD
Fluvastatin—HMGCR—bronchus—lung cancer	0.000311	0.0448	CbGeAlD
Fluvastatin—CYP2C8—mammary gland—lung cancer	0.000309	0.0445	CbGeAlD
Fluvastatin—HMGCR—trachea—lung cancer	0.000279	0.0402	CbGeAlD
Fluvastatin—CYP2C9—mammary gland—lung cancer	0.000274	0.0395	CbGeAlD
Fluvastatin—HMGCR—cardiac atrium—lung cancer	0.000262	0.0378	CbGeAlD
Fluvastatin—Rosuvastatin—ALB—lung cancer	0.000242	0.0683	CrCbGaD
Fluvastatin—HMGCR—bone marrow—lung cancer	0.000221	0.0319	CbGeAlD
Fluvastatin—Pitavastatin—ALB—lung cancer	0.000211	0.0597	CrCbGaD
Fluvastatin—Pitavastatin—ABCB1—lung cancer	0.000201	0.057	CrCbGaD
Fluvastatin—HMGCR—lung—lung cancer	0.000201	0.0289	CbGeAlD
Fluvastatin—CYP1A2—respiratory system—lung cancer	0.000193	0.0278	CbGeAlD
Fluvastatin—CYP1A1—respiratory system—lung cancer	0.00019	0.0274	CbGeAlD
Fluvastatin—CYP3A5—respiratory system—lung cancer	0.000186	0.0268	CbGeAlD
Fluvastatin—CYP2B6—respiratory system—lung cancer	0.000185	0.0266	CbGeAlD
Fluvastatin—SLCO2B1—lung—lung cancer	0.00017	0.0245	CbGeAlD
Fluvastatin—Atorvastatin—ABCB1—lung cancer	0.000162	0.046	CrCbGaD
Fluvastatin—CYP1A1—epithelium—lung cancer	0.000159	0.0229	CbGeAlD
Fluvastatin—CYP1A1—bronchus—lung cancer	0.000156	0.0225	CbGeAlD
Fluvastatin—CYP2B6—bronchus—lung cancer	0.000152	0.0219	CbGeAlD
Fluvastatin—CYP1A1—trachea—lung cancer	0.00014	0.0202	CbGeAlD
Fluvastatin—HMGCR—lymph node—lung cancer	0.000137	0.0198	CbGeAlD
Fluvastatin—CYP1A1—cardiac atrium—lung cancer	0.000132	0.019	CbGeAlD
Fluvastatin—SLCO2B1—lymph node—lung cancer	0.000116	0.0168	CbGeAlD
Fluvastatin—CYP1A2—lung—lung cancer	0.000102	0.0147	CbGeAlD
Fluvastatin—CYP1A1—lung—lung cancer	0.000101	0.0145	CbGeAlD
Fluvastatin—CYP3A5—lung—lung cancer	9.86e-05	0.0142	CbGeAlD
Fluvastatin—CYP2B6—lung—lung cancer	9.8e-05	0.0141	CbGeAlD
Fluvastatin—CYP1A1—lymph node—lung cancer	6.9e-05	0.00994	CbGeAlD
Fluvastatin—Paraesthesia—Etoposide—lung cancer	6.23e-05	0.000537	CcSEcCtD
Fluvastatin—Loss of consciousness—Docetaxel—lung cancer	6.21e-05	0.000535	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—lung cancer	6.2e-05	0.000535	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.2e-05	0.000534	CcSEcCtD
Fluvastatin—Dyspnoea—Etoposide—lung cancer	6.18e-05	0.000533	CcSEcCtD
Fluvastatin—Cough—Docetaxel—lung cancer	6.16e-05	0.000531	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—lung cancer	6.16e-05	0.000531	CcSEcCtD
Fluvastatin—Insomnia—Paclitaxel—lung cancer	6.15e-05	0.00053	CcSEcCtD
Fluvastatin—Hypersensitivity—Irinotecan—lung cancer	6.14e-05	0.00053	CcSEcCtD
Fluvastatin—Paraesthesia—Paclitaxel—lung cancer	6.11e-05	0.000526	CcSEcCtD
Fluvastatin—Hypertension—Docetaxel—lung cancer	6.1e-05	0.000526	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—lung cancer	6.08e-05	0.000524	CcSEcCtD
Fluvastatin—Dyspnoea—Paclitaxel—lung cancer	6.06e-05	0.000523	CcSEcCtD
Fluvastatin—Decreased appetite—Etoposide—lung cancer	6.03e-05	0.00052	CcSEcCtD
Fluvastatin—Myalgia—Docetaxel—lung cancer	6.01e-05	0.000518	CcSEcCtD
Fluvastatin—Chest pain—Docetaxel—lung cancer	6.01e-05	0.000518	CcSEcCtD
Fluvastatin—Arthralgia—Docetaxel—lung cancer	6.01e-05	0.000518	CcSEcCtD
Fluvastatin—Nausea—Vinorelbine—lung cancer	6e-05	0.000518	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Etoposide—lung cancer	5.99e-05	0.000516	CcSEcCtD
Fluvastatin—Dyspepsia—Paclitaxel—lung cancer	5.99e-05	0.000516	CcSEcCtD
Fluvastatin—Body temperature increased—Cisplatin—lung cancer	5.98e-05	0.000516	CcSEcCtD
Fluvastatin—Asthenia—Irinotecan—lung cancer	5.98e-05	0.000516	CcSEcCtD
Fluvastatin—Fatigue—Etoposide—lung cancer	5.98e-05	0.000515	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.97e-05	0.000515	CcSEcCtD
Fluvastatin—Constipation—Etoposide—lung cancer	5.93e-05	0.000511	CcSEcCtD
Fluvastatin—Pain—Etoposide—lung cancer	5.93e-05	0.000511	CcSEcCtD
Fluvastatin—Decreased appetite—Paclitaxel—lung cancer	5.91e-05	0.00051	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—lung cancer	5.88e-05	0.000507	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Paclitaxel—lung cancer	5.87e-05	0.000506	CcSEcCtD
Fluvastatin—Fatigue—Paclitaxel—lung cancer	5.86e-05	0.000505	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—lung cancer	5.85e-05	0.000504	CcSEcCtD
Fluvastatin—Asthenia—Gemcitabine—lung cancer	5.83e-05	0.000502	CcSEcCtD
Fluvastatin—Pain—Paclitaxel—lung cancer	5.81e-05	0.000501	CcSEcCtD
Fluvastatin—Constipation—Paclitaxel—lung cancer	5.81e-05	0.000501	CcSEcCtD
Fluvastatin—Confusional state—Docetaxel—lung cancer	5.81e-05	0.000501	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—lung cancer	5.8e-05	0.0005	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—lung cancer	5.77e-05	0.000498	CcSEcCtD
Fluvastatin—Anaphylactic shock—Docetaxel—lung cancer	5.76e-05	0.000497	CcSEcCtD
Fluvastatin—Pruritus—Gemcitabine—lung cancer	5.75e-05	0.000495	CcSEcCtD
Fluvastatin—Infection—Docetaxel—lung cancer	5.73e-05	0.000494	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—lung cancer	5.72e-05	0.000493	CcSEcCtD
Fluvastatin—Diarrhoea—Irinotecan—lung cancer	5.7e-05	0.000492	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Etoposide—lung cancer	5.67e-05	0.000489	CcSEcCtD
Fluvastatin—Shock—Docetaxel—lung cancer	5.67e-05	0.000489	CcSEcCtD
Fluvastatin—Nervous system disorder—Docetaxel—lung cancer	5.65e-05	0.000487	CcSEcCtD
Fluvastatin—Thrombocytopenia—Docetaxel—lung cancer	5.64e-05	0.000486	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—lung cancer	5.64e-05	0.000486	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—lung cancer	5.64e-05	0.000486	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—lung cancer	5.63e-05	0.000486	CcSEcCtD
Fluvastatin—Feeling abnormal—Paclitaxel—lung cancer	5.6e-05	0.000483	CcSEcCtD
Fluvastatin—Skin disorder—Docetaxel—lung cancer	5.6e-05	0.000483	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.59e-05	0.000482	CcSEcCtD
Fluvastatin—Hypersensitivity—Cisplatin—lung cancer	5.58e-05	0.000481	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Paclitaxel—lung cancer	5.56e-05	0.000479	CcSEcCtD
Fluvastatin—Diarrhoea—Gemcitabine—lung cancer	5.56e-05	0.000479	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—lung cancer	5.53e-05	0.000477	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—lung cancer	5.53e-05	0.000477	CcSEcCtD
Fluvastatin—Dizziness—Irinotecan—lung cancer	5.51e-05	0.000475	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—lung cancer	5.51e-05	0.000475	CcSEcCtD
Fluvastatin—Anorexia—Docetaxel—lung cancer	5.49e-05	0.000474	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—lung cancer	5.48e-05	0.000473	CcSEcCtD
Fluvastatin—Body temperature increased—Etoposide—lung cancer	5.48e-05	0.000473	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—lung cancer	5.48e-05	0.000473	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—lung cancer	5.48e-05	0.000473	CcSEcCtD
Fluvastatin—Asthenia—Cisplatin—lung cancer	5.43e-05	0.000468	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—lung cancer	5.43e-05	0.000468	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—lung cancer	5.41e-05	0.000466	CcSEcCtD
Fluvastatin—Urticaria—Paclitaxel—lung cancer	5.4e-05	0.000466	CcSEcCtD
Fluvastatin—Abdominal pain—Paclitaxel—lung cancer	5.38e-05	0.000463	CcSEcCtD
Fluvastatin—Body temperature increased—Paclitaxel—lung cancer	5.38e-05	0.000463	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—lung cancer	5.33e-05	0.00046	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—lung cancer	5.3e-05	0.000457	CcSEcCtD
Fluvastatin—Vomiting—Irinotecan—lung cancer	5.3e-05	0.000457	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—lung cancer	5.29e-05	0.000456	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—lung cancer	5.28e-05	0.000455	CcSEcCtD
Fluvastatin—Rash—Irinotecan—lung cancer	5.26e-05	0.000453	CcSEcCtD
Fluvastatin—Dermatitis—Irinotecan—lung cancer	5.25e-05	0.000453	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Docetaxel—lung cancer	5.25e-05	0.000453	CcSEcCtD
Fluvastatin—Chills—Methotrexate—lung cancer	5.25e-05	0.000452	CcSEcCtD
Fluvastatin—Headache—Irinotecan—lung cancer	5.22e-05	0.00045	CcSEcCtD
Fluvastatin—Insomnia—Docetaxel—lung cancer	5.21e-05	0.000449	CcSEcCtD
Fluvastatin—Diarrhoea—Cisplatin—lung cancer	5.18e-05	0.000447	CcSEcCtD
Fluvastatin—Paraesthesia—Docetaxel—lung cancer	5.18e-05	0.000446	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—lung cancer	5.17e-05	0.000445	CcSEcCtD
Fluvastatin—Vomiting—Gemcitabine—lung cancer	5.16e-05	0.000445	CcSEcCtD
Fluvastatin—Dyspnoea—Docetaxel—lung cancer	5.14e-05	0.000443	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—lung cancer	5.12e-05	0.000442	CcSEcCtD
Fluvastatin—Rash—Gemcitabine—lung cancer	5.12e-05	0.000441	CcSEcCtD
Fluvastatin—Dermatitis—Gemcitabine—lung cancer	5.12e-05	0.000441	CcSEcCtD
Fluvastatin—Hypersensitivity—Etoposide—lung cancer	5.11e-05	0.00044	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—lung cancer	5.09e-05	0.000439	CcSEcCtD
Fluvastatin—Headache—Gemcitabine—lung cancer	5.09e-05	0.000439	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—lung cancer	5.08e-05	0.000438	CcSEcCtD
Fluvastatin—Dyspepsia—Docetaxel—lung cancer	5.07e-05	0.000437	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—lung cancer	5.06e-05	0.000436	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—lung cancer	5.04e-05	0.000434	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—lung cancer	5.03e-05	0.000433	CcSEcCtD
Fluvastatin—Decreased appetite—Docetaxel—lung cancer	5.01e-05	0.000432	CcSEcCtD
Fluvastatin—Hypersensitivity—Paclitaxel—lung cancer	5.01e-05	0.000432	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—lung cancer	4.99e-05	0.00043	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—lung cancer	4.98e-05	0.00043	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Docetaxel—lung cancer	4.98e-05	0.000429	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—lung cancer	4.98e-05	0.000429	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—lung cancer	4.98e-05	0.000429	CcSEcCtD
Fluvastatin—Fatigue—Docetaxel—lung cancer	4.97e-05	0.000428	CcSEcCtD
Fluvastatin—Nausea—Irinotecan—lung cancer	4.95e-05	0.000427	CcSEcCtD
Fluvastatin—Pain—Docetaxel—lung cancer	4.93e-05	0.000425	CcSEcCtD
Fluvastatin—Constipation—Docetaxel—lung cancer	4.93e-05	0.000425	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—lung cancer	4.92e-05	0.000424	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—lung cancer	4.91e-05	0.000423	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—lung cancer	4.88e-05	0.000421	CcSEcCtD
Fluvastatin—Asthenia—Paclitaxel—lung cancer	4.88e-05	0.000421	CcSEcCtD
Fluvastatin—Nausea—Gemcitabine—lung cancer	4.82e-05	0.000416	CcSEcCtD
Fluvastatin—Vomiting—Cisplatin—lung cancer	4.81e-05	0.000415	CcSEcCtD
Fluvastatin—Pruritus—Paclitaxel—lung cancer	4.81e-05	0.000415	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—lung cancer	4.79e-05	0.000413	CcSEcCtD
Fluvastatin—Rash—Cisplatin—lung cancer	4.77e-05	0.000411	CcSEcCtD
Fluvastatin—Dermatitis—Cisplatin—lung cancer	4.77e-05	0.000411	CcSEcCtD
Fluvastatin—Feeling abnormal—Docetaxel—lung cancer	4.75e-05	0.000409	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—lung cancer	4.75e-05	0.000409	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—lung cancer	4.72e-05	0.000407	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Docetaxel—lung cancer	4.71e-05	0.000406	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—lung cancer	4.7e-05	0.000405	CcSEcCtD
Fluvastatin—Flushing—Doxorubicin—lung cancer	4.7e-05	0.000405	CcSEcCtD
Fluvastatin—Diarrhoea—Paclitaxel—lung cancer	4.65e-05	0.000401	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—lung cancer	4.59e-05	0.000396	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—lung cancer	4.59e-05	0.000396	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—lung cancer	4.59e-05	0.000395	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—lung cancer	4.57e-05	0.000394	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—lung cancer	4.57e-05	0.000394	CcSEcCtD
Fluvastatin—Body temperature increased—Docetaxel—lung cancer	4.56e-05	0.000393	CcSEcCtD
Fluvastatin—Abdominal pain—Docetaxel—lung cancer	4.56e-05	0.000393	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—lung cancer	4.56e-05	0.000393	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—lung cancer	4.54e-05	0.000392	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—lung cancer	4.52e-05	0.00039	CcSEcCtD
Fluvastatin—Dizziness—Paclitaxel—lung cancer	4.5e-05	0.000388	CcSEcCtD
Fluvastatin—Nausea—Cisplatin—lung cancer	4.5e-05	0.000388	CcSEcCtD
Fluvastatin—Alopecia—Doxorubicin—lung cancer	4.47e-05	0.000386	CcSEcCtD
Fluvastatin—Cough—Methotrexate—lung cancer	4.44e-05	0.000383	CcSEcCtD
Fluvastatin—Mental disorder—Doxorubicin—lung cancer	4.44e-05	0.000382	CcSEcCtD
Fluvastatin—Vomiting—Etoposide—lung cancer	4.41e-05	0.00038	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—lung cancer	4.41e-05	0.00038	CcSEcCtD
Fluvastatin—Rash—Etoposide—lung cancer	4.37e-05	0.000377	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—lung cancer	4.37e-05	0.000377	CcSEcCtD
Fluvastatin—Headache—Etoposide—lung cancer	4.34e-05	0.000375	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—lung cancer	4.34e-05	0.000374	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—lung cancer	4.33e-05	0.000374	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—lung cancer	4.33e-05	0.000374	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—lung cancer	4.33e-05	0.000374	CcSEcCtD
Fluvastatin—Vomiting—Paclitaxel—lung cancer	4.32e-05	0.000373	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—lung cancer	4.32e-05	0.000372	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.3e-05	0.000371	CcSEcCtD
Fluvastatin—Rash—Paclitaxel—lung cancer	4.29e-05	0.00037	CcSEcCtD
Fluvastatin—Dermatitis—Paclitaxel—lung cancer	4.28e-05	0.000369	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—lung cancer	4.28e-05	0.000369	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—lung cancer	4.26e-05	0.000368	CcSEcCtD
Fluvastatin—Headache—Paclitaxel—lung cancer	4.26e-05	0.000367	CcSEcCtD
Fluvastatin—Hypersensitivity—Docetaxel—lung cancer	4.25e-05	0.000366	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—lung cancer	4.24e-05	0.000365	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—lung cancer	4.19e-05	0.000361	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—lung cancer	4.15e-05	0.000358	CcSEcCtD
Fluvastatin—Asthenia—Docetaxel—lung cancer	4.14e-05	0.000356	CcSEcCtD
Fluvastatin—Infection—Methotrexate—lung cancer	4.13e-05	0.000356	CcSEcCtD
Fluvastatin—Nausea—Etoposide—lung cancer	4.12e-05	0.000355	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—lung cancer	4.09e-05	0.000353	CcSEcCtD
Fluvastatin—Pruritus—Docetaxel—lung cancer	4.08e-05	0.000352	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—lung cancer	4.07e-05	0.000351	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—lung cancer	4.07e-05	0.000351	CcSEcCtD
Fluvastatin—Nausea—Paclitaxel—lung cancer	4.04e-05	0.000348	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—lung cancer	4.04e-05	0.000348	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—lung cancer	4.02e-05	0.000346	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—lung cancer	3.97e-05	0.000343	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—lung cancer	3.96e-05	0.000341	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—lung cancer	3.96e-05	0.000341	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—lung cancer	3.95e-05	0.000341	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—lung cancer	3.95e-05	0.00034	CcSEcCtD
Fluvastatin—Diarrhoea—Docetaxel—lung cancer	3.94e-05	0.00034	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—lung cancer	3.87e-05	0.000334	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—lung cancer	3.85e-05	0.000332	CcSEcCtD
Fluvastatin—Dizziness—Docetaxel—lung cancer	3.81e-05	0.000329	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—lung cancer	3.81e-05	0.000328	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—lung cancer	3.78e-05	0.000326	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—lung cancer	3.76e-05	0.000324	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—lung cancer	3.75e-05	0.000323	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—lung cancer	3.75e-05	0.000323	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—lung cancer	3.75e-05	0.000323	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—lung cancer	3.74e-05	0.000322	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—lung cancer	3.73e-05	0.000322	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.73e-05	0.000321	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—lung cancer	3.71e-05	0.00032	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—lung cancer	3.7e-05	0.000319	CcSEcCtD
Fluvastatin—Vomiting—Docetaxel—lung cancer	3.66e-05	0.000316	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—lung cancer	3.66e-05	0.000315	CcSEcCtD
Fluvastatin—Rash—Docetaxel—lung cancer	3.63e-05	0.000313	CcSEcCtD
Fluvastatin—Dermatitis—Docetaxel—lung cancer	3.63e-05	0.000313	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—lung cancer	3.63e-05	0.000313	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—lung cancer	3.61e-05	0.000311	CcSEcCtD
Fluvastatin—Headache—Docetaxel—lung cancer	3.61e-05	0.000311	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—lung cancer	3.6e-05	0.00031	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—lung cancer	3.59e-05	0.000309	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—lung cancer	3.58e-05	0.000309	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—lung cancer	3.57e-05	0.000308	CcSEcCtD
Fluvastatin—Pain—Methotrexate—lung cancer	3.55e-05	0.000306	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—lung cancer	3.54e-05	0.000305	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—lung cancer	3.53e-05	0.000304	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—lung cancer	3.52e-05	0.000304	CcSEcCtD
Fluvastatin—Skin disorder—Doxorubicin—lung cancer	3.49e-05	0.000301	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—lung cancer	3.48e-05	0.0003	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—lung cancer	3.43e-05	0.000296	CcSEcCtD
Fluvastatin—Nausea—Docetaxel—lung cancer	3.42e-05	0.000295	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—lung cancer	3.42e-05	0.000295	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—lung cancer	3.4e-05	0.000293	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—lung cancer	3.3e-05	0.000284	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—lung cancer	3.28e-05	0.000283	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—lung cancer	3.28e-05	0.000283	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.28e-05	0.000283	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—lung cancer	3.25e-05	0.00028	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—lung cancer	3.23e-05	0.000278	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—lung cancer	3.21e-05	0.000276	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—lung cancer	3.17e-05	0.000273	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—lung cancer	3.13e-05	0.00027	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—lung cancer	3.11e-05	0.000268	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—lung cancer	3.1e-05	0.000267	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—lung cancer	3.08e-05	0.000265	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—lung cancer	3.08e-05	0.000265	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—lung cancer	3.06e-05	0.000264	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—lung cancer	2.98e-05	0.000257	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—lung cancer	2.96e-05	0.000256	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—lung cancer	2.94e-05	0.000254	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—lung cancer	2.94e-05	0.000253	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—lung cancer	2.86e-05	0.000246	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—lung cancer	2.84e-05	0.000245	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—lung cancer	2.84e-05	0.000245	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—lung cancer	2.84e-05	0.000245	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—lung cancer	2.75e-05	0.000237	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—lung cancer	2.65e-05	0.000228	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—lung cancer	2.64e-05	0.000228	CcSEcCtD
Fluvastatin—Rash—Methotrexate—lung cancer	2.62e-05	0.000226	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—lung cancer	2.62e-05	0.000226	CcSEcCtD
Fluvastatin—Headache—Methotrexate—lung cancer	2.6e-05	0.000224	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—lung cancer	2.58e-05	0.000222	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—lung cancer	2.54e-05	0.000219	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—lung cancer	2.47e-05	0.000213	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—lung cancer	2.46e-05	0.000212	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—lung cancer	2.38e-05	0.000205	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—lung cancer	2.29e-05	0.000197	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—lung cancer	2.27e-05	0.000196	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—lung cancer	2.27e-05	0.000195	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—lung cancer	2.25e-05	0.000194	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—lung cancer	2.14e-05	0.000184	CcSEcCtD
Fluvastatin—CYP3A4—Metabolism—GSTA4—lung cancer	3.2e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—TYMS—lung cancer	3.2e-06	3.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—NQO1—lung cancer	3.19e-06	3.43e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.17e-06	3.41e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CAT—lung cancer	3.16e-06	3.4e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTM1—lung cancer	3.16e-06	3.4e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTEN—lung cancer	3.15e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.14e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ADCY1—lung cancer	3.14e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ABCG2—lung cancer	3.14e-06	3.38e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.12e-06	3.36e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA2—lung cancer	3.12e-06	3.35e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CD—lung cancer	3.11e-06	3.34e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—HPGDS—lung cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO2—lung cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ABCB1—lung cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—ALB—lung cancer	3.07e-06	3.3e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CYP1A1—lung cancer	3.07e-06	3.29e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.06e-06	3.29e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ERCC2—lung cancer	3.04e-06	3.27e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.02e-06	3.25e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.02e-06	3.25e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—TYMS—lung cancer	3.02e-06	3.25e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTA1—lung cancer	3.01e-06	3.23e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—EP300—lung cancer	3e-06	3.22e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CYP1A1—lung cancer	3e-06	3.22e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTT1—lung cancer	2.99e-06	3.21e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTM1—lung cancer	2.99e-06	3.21e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—lung cancer	2.98e-06	3.2e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCC3—lung cancer	2.97e-06	3.2e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ERCC2—lung cancer	2.97e-06	3.19e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP2E1—lung cancer	2.97e-06	3.19e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CB—lung cancer	2.96e-06	3.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GCLC—lung cancer	2.95e-06	3.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP2A6—lung cancer	2.95e-06	3.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.94e-06	3.16e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP2E1—lung cancer	2.94e-06	3.16e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—NQO1—lung cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—lung cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—NQO1—lung cancer	2.91e-06	3.12e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CAT—lung cancer	2.9e-06	3.12e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.88e-06	3.1e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKR1C1—lung cancer	2.88e-06	3.1e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—STK11—lung cancer	2.87e-06	3.09e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.85e-06	3.06e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.82e-06	3.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ABCB1—lung cancer	2.82e-06	3.03e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ERCC2—lung cancer	2.81e-06	3.02e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ENO1—lung cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—UGT1A1—lung cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.79e-06	3e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—TYMS—lung cancer	2.77e-06	2.98e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.75e-06	2.96e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTM1—lung cancer	2.74e-06	2.94e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.71e-06	2.91e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.7e-06	2.9e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GNG11—lung cancer	2.7e-06	2.9e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—lung cancer	2.69e-06	2.89e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—lung cancer	2.66e-06	2.86e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—STK11—lung cancer	2.64e-06	2.84e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—APOA1—lung cancer	2.63e-06	2.83e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—STK11—lung cancer	2.62e-06	2.82e-05	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—AKT1—lung cancer	2.62e-06	2.81e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PIK3CA—lung cancer	2.61e-06	2.81e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CYP1A1—lung cancer	2.6e-06	2.79e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CAT—lung cancer	2.59e-06	2.78e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ERCC2—lung cancer	2.57e-06	2.77e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.57e-06	2.77e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—APOA1—lung cancer	2.57e-06	2.76e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALDOA—lung cancer	2.57e-06	2.76e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTEN—lung cancer	2.56e-06	2.75e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ABCB1—lung cancer	2.52e-06	2.71e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP2E1—lung cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NCOA3—lung cancer	2.49e-06	2.68e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—NQO1—lung cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TYMS—lung cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.46e-06	2.64e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PIK3CA—lung cancer	2.46e-06	2.64e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—lung cancer	2.45e-06	2.63e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTM1—lung cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—EP300—lung cancer	2.44e-06	2.62e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—APOA1—lung cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ADCY1—lung cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCG2—lung cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—lung cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.41e-06	2.59e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CG—lung cancer	2.4e-06	2.58e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CAT—lung cancer	2.38e-06	2.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO2—lung cancer	2.38e-06	2.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—HPGDS—lung cancer	2.38e-06	2.56e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CAT—lung cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CG—lung cancer	2.35e-06	2.52e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.35e-06	2.52e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTEN—lung cancer	2.34e-06	2.52e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.33e-06	2.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CYP1A1—lung cancer	2.32e-06	2.49e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ABCB1—lung cancer	2.31e-06	2.49e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTT1—lung cancer	2.31e-06	2.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ERCC2—lung cancer	2.3e-06	2.47e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ABCB1—lung cancer	2.29e-06	2.47e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—POMC—lung cancer	2.29e-06	2.46e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GCLC—lung cancer	2.28e-06	2.45e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP2A6—lung cancer	2.28e-06	2.45e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TYMS—lung cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TYMS—lung cancer	2.25e-06	2.42e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTM1—lung cancer	2.25e-06	2.42e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—STK11—lung cancer	2.24e-06	2.41e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—POMC—lung cancer	2.23e-06	2.4e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—EP300—lung cancer	2.23e-06	2.4e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTM1—lung cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—APOA1—lung cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CREBBP—lung cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PIK3CA—lung cancer	2.22e-06	2.39e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CG—lung cancer	2.22e-06	2.38e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CREBBP—lung cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ENO1—lung cancer	2.16e-06	2.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—AKT1—lung cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CYP1A1—lung cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ERCC2—lung cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CYP1A1—lung cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CD—lung cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—POMC—lung cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.1e-06	2.26e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ERCC2—lung cancer	2.09e-06	2.25e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—ALB—lung cancer	2.08e-06	2.24e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—lung cancer	2.07e-06	2.23e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CD—lung cancer	2.06e-06	2.22e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CREBBP—lung cancer	2.06e-06	2.21e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—ALB—lung cancer	2.04e-06	2.19e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CG—lung cancer	2.03e-06	2.18e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CAT—lung cancer	2.02e-06	2.17e-05	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—AKT1—lung cancer	2.01e-06	2.16e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2e-06	2.15e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—APOA1—lung cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ABCB1—lung cancer	1.96e-06	2.11e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CD—lung cancer	1.95e-06	2.09e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP2E1—lung cancer	1.94e-06	2.08e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—POMC—lung cancer	1.93e-06	2.08e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TYMS—lung cancer	1.93e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—ALB—lung cancer	1.92e-06	2.07e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—NQO1—lung cancer	1.92e-06	2.06e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTM1—lung cancer	1.9e-06	2.05e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.9e-06	2.05e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CREBBP—lung cancer	1.88e-06	2.03e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CB—lung cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—APOA1—lung cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—lung cancer	1.82e-06	1.96e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CG—lung cancer	1.81e-06	1.95e-05	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—AKT1—lung cancer	1.81e-06	1.95e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—APOA1—lung cancer	1.81e-06	1.95e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CYP1A1—lung cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PIK3CA—lung cancer	1.8e-06	1.94e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CB—lung cancer	1.8e-06	1.93e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ERCC2—lung cancer	1.79e-06	1.92e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CD—lung cancer	1.79e-06	1.92e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—lung cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—ALB—lung cancer	1.76e-06	1.9e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.74e-06	1.87e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—STK11—lung cancer	1.73e-06	1.86e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—POMC—lung cancer	1.73e-06	1.86e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CB—lung cancer	1.7e-06	1.83e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—lung cancer	1.68e-06	1.81e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CREBBP—lung cancer	1.68e-06	1.81e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CG—lung cancer	1.67e-06	1.79e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CG—lung cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—lung cancer	1.6e-06	1.72e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CD—lung cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTEN—lung cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—POMC—lung cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—POMC—lung cancer	1.57e-06	1.69e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—ALB—lung cancer	1.57e-06	1.69e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CB—lung cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CAT—lung cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTEN—lung cancer	1.55e-06	1.67e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—APOA1—lung cancer	1.55e-06	1.66e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CREBBP—lung cancer	1.55e-06	1.66e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—lung cancer	1.54e-06	1.66e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CREBBP—lung cancer	1.53e-06	1.65e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—EP300—lung cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ABCB1—lung cancer	1.51e-06	1.63e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TYMS—lung cancer	1.49e-06	1.6e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.48e-06	1.59e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—EP300—lung cancer	1.48e-06	1.59e-05	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—AKT1—lung cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTM1—lung cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTEN—lung cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CD—lung cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CD—lung cancer	1.45e-06	1.56e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—ALB—lung cancer	1.45e-06	1.56e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—ALB—lung cancer	1.44e-06	1.54e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CG—lung cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—EP300—lung cancer	1.4e-06	1.5e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CYP1A1—lung cancer	1.39e-06	1.5e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CB—lung cancer	1.39e-06	1.49e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ERCC2—lung cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—lung cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—AKT1—lung cancer	1.35e-06	1.45e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTEN—lung cancer	1.35e-06	1.45e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—POMC—lung cancer	1.35e-06	1.45e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CREBBP—lung cancer	1.31e-06	1.41e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—EP300—lung cancer	1.28e-06	1.38e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CB—lung cancer	1.28e-06	1.37e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CB—lung cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—lung cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—lung cancer	1.26e-06	1.35e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CD—lung cancer	1.24e-06	1.34e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—ALB—lung cancer	1.23e-06	1.32e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTEN—lung cancer	1.2e-06	1.29e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—APOA1—lung cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—EP300—lung cancer	1.15e-06	1.23e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PIK3CA—lung cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTEN—lung cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PIK3CA—lung cancer	1.1e-06	1.18e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTEN—lung cancer	1.1e-06	1.18e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CG—lung cancer	1.09e-06	1.17e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CB—lung cancer	1.08e-06	1.16e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—lung cancer	1.07e-06	1.15e-05	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—EP300—lung cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—EP300—lung cancer	1.04e-06	1.12e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—POMC—lung cancer	1.04e-06	1.12e-05	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PIK3CA—lung cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CREBBP—lung cancer	1.01e-06	1.09e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CD—lung cancer	9.59e-07	1.03e-05	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PIK3CA—lung cancer	9.49e-07	1.02e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—ALB—lung cancer	9.47e-07	1.02e-05	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTEN—lung cancer	9.36e-07	1.01e-05	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—AKT1—lung cancer	9.16e-07	9.85e-06	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—AKT1—lung cancer	8.96e-07	9.63e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—EP300—lung cancer	8.93e-07	9.59e-06	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PIK3CA—lung cancer	8.47e-07	9.11e-06	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—AKT1—lung cancer	8.46e-07	9.09e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CB—lung cancer	8.36e-07	8.99e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—lung cancer	8.28e-07	8.9e-06	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PIK3CA—lung cancer	7.79e-07	8.38e-06	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—AKT1—lung cancer	7.76e-07	8.34e-06	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PIK3CA—lung cancer	7.73e-07	8.31e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTEN—lung cancer	7.22e-07	7.76e-06	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—AKT1—lung cancer	6.92e-07	7.44e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—EP300—lung cancer	6.89e-07	7.4e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PIK3CA—lung cancer	6.6e-07	7.1e-06	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—AKT1—lung cancer	6.37e-07	6.84e-06	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—AKT1—lung cancer	6.31e-07	6.79e-06	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—AKT1—lung cancer	5.39e-07	5.8e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PIK3CA—lung cancer	5.1e-07	5.48e-06	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—AKT1—lung cancer	4.16e-07	4.47e-06	CbGpPWpGaD
